Time Inc. (TIME) Analysts See $0.78 EPS; Dreman Value Management Boosted By $448,834 Its Teva Pharmaceutical Industries LTD (TEVA) Position

January 14, 2018 - By Nellie Frank

Dreman Value Management Llc increased Teva Pharmaceutical Industries Ltd. (TEVA) stake by 168.75% reported in 2017Q3 SEC filing. Dreman Value Management Llc acquired 26,402 shares as Teva Pharmaceutical Industries Ltd. (TEVA)’s stock declined 15.11%. The Dreman Value Management Llc holds 42,048 shares with $740,000 value, up from 15,646 last quarter. Teva Pharmaceutical Industries Ltd. now has $22.42B valuation. The stock increased 1.52% or $0.33 during the last trading session, reaching $22.07. About 40.56 million shares traded or 52.13% up from the average. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 14, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Analysts expect Time Inc. (NYSE:TIME) to report $0.78 EPS on February, 15.They anticipate $0.03 EPS change or 4.00% from last quarter’s $0.75 EPS. TIME’s profit would be $77.70 million giving it 5.93 P/E if the $0.78 EPS is correct. After having $0.36 EPS previously, Time Inc.’s analysts see 116.67% EPS growth. The stock increased 0.27% or $0.05 during the last trading session, reaching $18.5. About 1.03 million shares traded. Time Inc. (NYSE:TIME) has declined 15.24% since January 14, 2017 and is downtrending. It has underperformed by 31.94% the S&P500.

Time Inc., together with its subsidiaries, operates as a multi-platform media and content firm the United States, the United Kingdom, and internationally. The company has market cap of $1.84 billion. It publishes approximately 75 magazine titles under the People, Time, Fortune, Sports Illustrated, InStyle, Real Simple, Southern Living, Entertainment Weekly, Food & Wine, Travel + Leisure, and Essence brands. It currently has negative earnings. The firm also provides content marketing and advertising services; digital products, such as programmatic offerings and custom display advertising on local and national Websites; print products, including customized geographic and demographic-targeted advertising programs in U.S. magazines; and cover wraps and other add-ons to magazines, allowing advertisers to distribute direct marketing messages to specific locations, such as medical offices.

Among 8 analysts covering Time (NYSE:TIME), 2 have Buy rating, 1 Sell and 5 Hold. Therefore 25% are positive. Time had 15 analyst reports since November 5, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Citigroup given on Monday, December 4. As per Friday, April 28, the company rating was downgraded by Wells Fargo. The company was maintained on Monday, October 23 by Morgan Stanley. The rating was upgraded by Stephens on Monday, March 20 to “Equal-Weight”. As per Friday, February 12, the company rating was upgraded by Gabelli. The company was upgraded on Thursday, May 19 by Macquarie Research. On Thursday, November 5 the stock rating was maintained by FBR Capital with “Outperform”. The firm earned “Outperform” rating on Tuesday, January 10 by Wells Fargo. The company was maintained on Tuesday, August 9 by Citigroup. The rating was maintained by FBR Capital on Friday, February 12 with “Outperform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: